Brazil is a major driver of Latin American healthcare expansion: total imports surged past $9 billion in 2024, up 18% from the year before. While growth is reliably strong, some core drivers of Brazil’s healthcare market are changing. Market shares among dominant importers have shifted. New clinical specialties emerged, reflecting the current needs of Brazil's population for advanced diagnostics and procedural technologies.
We rounded up the 40+ key statistics from our Brazil Medical Device Import Market Report to illustrate what’s consistent and what’s changing. The statistics are organized into five themes: overall market size and growth, the demographic and epidemiological forces, the competitive landscape by country of origin, fastest growing specialty segments growing fastest (and one that collapsed), and long-term projections by clinical area. Together, they offer a grounded picture of where Brazil's market stands, where it is headed, and where the risks are.
Brazil Medical Device Market Size & Overall Growth
Brazil's medical device import market has grown every year from 2021 through 2024, with growth accelerating as the period progressed. That trajectory reflects a market driven by durable demand. The statistics below illustrate the scale of that growth and the long-term projections built on top of it.
- Brazil’s total medical device and IVD imports reached USD $9.33 billion in 2024, positioning it as the largest MedTech import market in Latin America (UN Comtrade, 2025).
- Total imports grew 18.01% year-over-year in 2024, the market’s strongest performance in the four-year analysis period (UN Comtrade, 2025).
- The market expanded from $6.07 billion in 2021 to $9.33 billion in 2024, representing approximately 54% cumulative growth over four years (UN Comtrade, 2025).
- Year-over-year growth was 16.39% in 2022 and 11.95% in 2023 before accelerating to 18.01% in 2024, indicating momentum rather than deceleration (UN Comtrade, 2025).
- Brazil’s overall medical devices market is projected to grow at a CAGR of 5–7% through 2030 following recent regulatory updates (Fitch Solutions, 2024).
Demographic & Epidemiological Demand Drivers
Brazil's medical device market supports an aging population, chronic disease, strong demand for elective and aesthetic procedures, and a public health infrastructure that serves three-quarters of the population. The statistics in this section identify the specific demographic and epidemiological conditions dictating which specialties will see sustained demand.
- Brazil’s population aged 65 and over is projected to grow from 10.53% to 13.44% of the total population by 2030 (Mobility Foresights, 2023).
- Cardiovascular disease affects 27.5% of the Brazilian population as of 2022, creating substantial ongoing demand for diagnostic and interventional devices (Fortune Business Insights, 2024).
- An estimated 28 million Brazilians suffer from hearing problems, sustaining demand for ENT and hearing devices; the ENT market is projected to grow at approximately 7% CAGR (Research and Markets, 2025).
- 23% of Brazilians have untreated dental caries, and Brazil has become a major global destination for dental tourism, supporting steady demand for dental devices with a projected CAGR of 5.2%–8.1% (IMARC Group, 2024).
- Brazil ranks second worldwide in total annual plastic surgery procedures, performing an estimated 1.5 million+ procedures per year (Rocha et al., Pubmed, 2017).
- In 2016, Brazilian surgeons performed nearly 7 surgical procedures per 1,000 people — a higher rate than the United States — demonstrating high demand for surgical procedures (Rocha et al., Pubmed, 2017).
- Approximately 75% of the Brazilian population relies exclusively on the public Sistema Único de Saúde (SUS) for all healthcare services (The Commonwealth Fund, 2020).
Competitive Landscape: Country of Origin
Major market share holders stagnated in recent years, making room for new players. The United States remains the largest single exporter by value, but its market share has barely moved in four years. Meanwhile, Ireland, Austria, and France are targeting high value, fast-growing clinical segments while leveraging the recent harmonization between ANVISA and EU regulatory requirements to expedite market entry.
- The United States remains the single largest exporter of medical technology to Brazil, with $1.93 billion in 2024 imports and a 20.64% market share (UN Comtrade, 2025).
- Germany holds the number two position with $1.32 billion in 2024 imports, but its market share fell from a 2023 peak of 15.3% to 14.1% in 2024 (UN Comtrade, 2025).
- China’s market share fell from a 2022 peak of 16.58% to 12.42% in 2024, including an 11.91% import decline in 2023 (UN Comtrade, 2025).
- Austria is the fastest-growing major exporting country with back-to-back growth of 60.87% in 2023 and 60.38% in 2024 (UN Comtrade, 2025).
- France expanded with 49.23% growth in 2024, reaching $297.4 million and growing its market share to 3.19% (UN Comtrade, 2025).
Top Performing Medical Device Specialties in Brazil
Brazil is experiencing strong growth across a range of specialties. Immunology has become the single largest import category by a wide margin, and its growth rate is accelerating. Surgical specialties continue to perform, driven by strong demand for aesthetic procedures. However, neurology's collapse in 2024 is a reminder that policy decisions can influence market performance over clinical demand.
- Immunology is the single largest medical specialty import category at $3.69 billion in 2024 and growing (UN Comtrade, 2025).
- Immunodiagnostics represents 30.5% of Brazil’s entire IVD market in 2024, driven by the country’s high burden of infectious diseases including dengue, Zika, and HIV, as well as rising cancer cases (Mordor Intelligence, 2024).
- General & Plastic Surgery is the second-largest import category at $1.75 billion in 2024 with 13.31% growth, anchored by Brazil’s status as the world’s second-largest market for plastic surgery procedures (UN Comtrade, 2025).
- Clinical Chemistry imports reached $698.5 million in 2024 with 30.25% growth, rebounding powerfully from a 38.37% contraction in 2022 that reflected the end of large COVID-era public procurement cycles (UN Comtrade, 2025).
- Orthopedics reached $693.5 million in 2024, with growth moderating to 3.66% after a strong 15.13% in 2023 and 28.29% in 2022 (UN Comtrade, 2025).
- Radiology imports hit $664.7 million in 2024 with 15.37% growth, accelerating from 4.64% in 2023 as Brazil upgrades to digital, AI-integrated imaging systems (UN Comtrade, 2025).
- Hematology reached $577.0 million in 2024 with modest 3.94% growth, partially recovering from a 19.60% decline in 2023 that reflected the volatility typical of public-sector procurement cycles (UN Comtrade, 2025).
- Ophthalmic imports surged 16.65% to $375.2 million in 2024, rebounding from a flat 0.73% in 2023, driven by aging-population demand for cataract and glaucoma treatments (UN Comtrade, 2025).
Growth Projections by Medical Device Specialty
The projections below reflect how clinical and demographic demand could influence specialty growth through 2030, assuming a stable regulatory and reimbursement scenario. Some specialties that saw modest growth in recent years, including neurorehabilitation and radiology, are looking at the strongest long-term CAGR projections.
- Immunology imports are expected to maintain 25–30% annual growth driven by expanding test menus, laboratory automation, and continued public and private investment in diagnostic infrastructure (Mordor Intelligence, 2024).
- Brazil’s radiology services market is projected to expand at a CAGR of 15.7% through 2030, with the diagnostic imaging equipment market growing at 5–6% CAGR (Grand View Research, 2024).
- The neurorehabilitation devices market is projected at a CAGR of 15.1% through 2030, the highest long-term CAGR of any specialty in this dataset, despite the 2024 neurology import contraction (Grand View Research, 2024).
- Brazil’s cardiovascular devices market is projected to grow at a CAGR of 6.1%–8.13% through 2033, driven by the high prevalence of heart disease and aging demographics (Spherical Insights, 2024).
- The endoscopy devices market is projected at a CAGR of 7.8%, driven by the adoption of robot-assisted procedures and endoscopic bariatric surgeries (Grand View Research, 2024).
- Brazil’s clinical microbiology market is projected to grow at a CAGR of 7.7%, driven by high infectious disease prevalence and government support through the public health system (Grand View Research, 2024).
- The urology devices market is projected at a CAGR of 7.6% through 2030, supported by over 23 million nephrology and urology procedures performed annually (Grand View Research, 2024).
- Brazil’s tissue diagnostics market is projected at a CAGR of 7.1%, with digital pathology and AI-powered workflow solutions identified as the fastest-growing sub-segment (Grand View Research, 2024).
- The orthopedic devices market is projected to grow at a CAGR of 5.1% through 2030, anchored by aging-population demand for joint replacement systems, trauma fixation devices, and spinal implants (Grand View Research, 2024).
Ready to Enter Brazil?
The data paints a clear picture. Brazil’s overall market growth is steady with no signs of slowing down, making it an obvious target for manufacturers looking at Latin America. But manufacturers in high-growth specialties like immunology and surgical have a unique opportunity to capitalize on Brazil’s niche growth in these areas. Timing is still key, as policy and reimbursement changes can alter the trajectory of the market with little warning.
Efficient market entry strategies and maintaining predictable operating costs over time makes sense for all manufacturers planning to register medical devices in Brazil, regardless of specialty. Pure Global’s AI-supported dossier capabilities leverage your existing documentation to prepare your ANVISA dossier in half the time. Paired with annual flat-fee pricing for in-country representation and dossier preparation, Pure Global is partnering with manufacturers to enter Brazil on shorter timelines with predictable costs. Learn more about Brazil medical device registration.
.jpg)
